2024-04-24 10:37 | CC:LSL | LSL Pharma Group Inc | 0.40 | News Release200 | LSL Pharma closes $3.79M final tranche of financing |
2024-04-23 09:50 | CC:LSL | LSL Pharma Group Inc | 0.41 | News Release200 | LSL Pharma appoints Beaudry, Paradis as directors |
2024-04-12 16:47 | CC:LSL | LSL Pharma Group Inc | 0.40 | Shares for Debt330 | LSL Pharma 9,373,327 shares for debt |
2024-04-11 11:02 | CC:LSL | LSL Pharma Group Inc | 0.41 | News Release200 | LSL Pharma increases private placement to $7.5-million |
2024-03-19 09:58 | CC:LSL | LSL Pharma Group Inc | 0.40 | News Release200 | LSL Pharma closes private placements for $6.43-million |
2024-03-07 09:48 | CC:LSL | LSL Pharma Group Inc | 0.41 | News Release200 | LSL Pharma arranges financings for up to $8-million |
2024-01-08 09:52 | CC:LSL | LSL Pharma Group Inc | 0.51 | News Release200 | LSL Pharma extends private placement to Feb. 7 |
2023-12-08 13:06 | CC:LSL | LSL Pharma Group Inc | 0.46 | News Release200 | LSL Pharma closes $995,000 second tranche of financing |
2023-12-04 10:50 | CC:LSL | LSL Pharma Group Inc | 0.415 | News Release200 | LSL Pharma appoints Mainville as SVP, CFO |
2023-11-29 11:40 | CC:LSL | LSL Pharma Group Inc | 0.42 | News Release200 | LSL Pharma Group loses $762,000 in Q3 2023 |
2023-11-29 08:47 | CC:LSL | LSL Pharma Group Inc | 0.44 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2023-11-29 08:47 | CC:LSL | LSL Pharma Group Inc | 0.44 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2023-11-29 08:41 | CC:LSL | LSL Pharma Group Inc | 0.44 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-11-01 14:05 | CC:LSL | LSL Pharma Group Inc | 0.465 | News Release200 | LSL Pharma closes $2.29-million 1st tranche of offering |
2023-10-25 09:02 | CC:LSL | LSL Pharma Group Inc | 0.40 | News Release200 | LSL Pharma receives orders with annual revenue of $2.6M |
2023-10-18 09:33 | CC:LSL | LSL Pharma Group Inc | 0.40 | News Release200 | LSL Pharma, Fera to provide eye meds for U.S. newborns |
2023-10-06 10:17 | CC:LSL | LSL Pharma Group Inc | 0.43 | News Release200 | LSL Pharma hires Paradox for IR services |
2023-09-21 11:34 | CC:LSL | LSL Pharma Group Inc | 0.47 | News Release200 | LSL Pharma Group arranges $4-million private placement |
2023-08-30 00:04 | CC:LSL | LSL Pharma Group Inc | 0.49 | News Release200 | LSL Pharma loses $3.1-million in Q2 |
2023-08-29 14:24 | CC:LSL | LSL Pharma Group Inc | 0.49 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2023-08-29 14:18 | CC:LSL | LSL Pharma Group Inc | 0.49 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2023-08-29 14:12 | CC:LSL | LSL Pharma Group Inc | 0.49 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-06-20 18:04 | CC:LSL | LSL Pharma Group Inc | 0.485 | News Release200 | LSL Pharma to boost production capacity by up to 40% |
2023-05-30 20:48 | CC:LSL | LSL Pharma Group Inc | 0.56 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-05-30 20:48 | CC:LSL | LSL Pharma Group Inc | 0.56 | SEDAR MD & A815 | SEDAR MD & A |